ConductScience.org, home

Paper20046464

The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring.

Filler G and 1 other. Paediatr Child Health, 2002. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring. Papers, record 20046464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20046464

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring.
PubMed
Journal
Paediatr Child Health
PubMed
Year
2002
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2024-03-22
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Filler GGuido
2Feber JJanusz

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110684356Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.Pediatr Nephrol2000https://conductscience.org/library/papers/10684356PubMed
29402690Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.Transpl Immunol1997https://conductscience.org/library/papers/9402690PubMed
39636479Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.Transplant Proc1998https://conductscience.org/library/papers/9636479PubMed
48697605Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.Clin Chem1996https://conductscience.org/library/papers/8697605PubMed
510213717Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials.BMJ1999https://conductscience.org/library/papers/10213717PubMed
68888202Which cyclosporin formulation?Lancet1996https://conductscience.org/library/papers/8888202PubMed
711579295Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.Transplantation2001https://conductscience.org/library/papers/11579295PubMed
810051052Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation.Ther Drug Monit1999https://conductscience.org/library/papers/10051052PubMed
910774628Limited sampling strategy for mycophenolic acid area under the curve.Ther Drug Monit2000https://conductscience.org/library/papers/10774628PubMed
1010684355Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children.Pediatr Nephrol2000https://conductscience.org/library/papers/10684355PubMed
119269646Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9269646PubMed
1211294511Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.Ther Drug Monit2001https://conductscience.org/library/papers/11294511PubMed
133048779Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants.Clin Chem1988https://conductscience.org/library/papers/3048779PubMed
1410589962Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.Transplantation1999https://conductscience.org/library/papers/10589962PubMed
157478104Mycophenolate mofetil (RS 61443): nothing new under the sun or an important break-through in the field of transplantation?Nephrol Dial Transplant1995https://conductscience.org/library/papers/7478104PubMed
169132677Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9132677PubMed
179697675
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.
J Am Soc Nephrol1998https://conductscience.org/library/papers/9697675PubMed
1810228992Abbreviated cyclosporine AUCs on Neoral--the search continues!Pediatr Nephrol1999https://conductscience.org/library/papers/10228992PubMed
197752752Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.Lancet1995https://conductscience.org/library/papers/7752752PubMed
208728345Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration.J Clin Pharmacol1996https://conductscience.org/library/papers/8728345PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42281857Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm.World J Transplant2026https://conductscience.org/library/papers/42281857PubMed
37493886Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling.Clin Pharmacokinet2023https://conductscience.org/library/papers/37493886PubMed
28353583Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.Medicine (Baltimore)2017https://conductscience.org/library/papers/28353583PubMed
17523697Calcineurin inhibitors in pediatric renal transplant recipients.Paediatr Drugs2007https://conductscience.org/library/papers/17523697PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20046464

GET https://conductscience.org/api/papers/v1/20046464/references?page=2